Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03937895
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2019-04-29
Brief Title:
Allogeneic NK Cell SMT-NK in Combination With Pembrolizumab in Advanced Biliary Tract Cancer
Sponsor:
SMT bio Co Ltd
Organization:
SMT bio Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-08
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-29
First Submit QC Date:
May 2 2019
Study First Post Date:
2019-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-28
Last Update Post Date:
2022-03-29
Last Update Post Date Type:
ACTUAL